Preimplantation Genetic Testing in IVF Should be a Routine Precaution

0 Shares
0
0
0

Since the introduction of pre-implantation genetic testing PGT in assisted reproductive technology, it has become a routine to examine for missing or extra chromosomes known as aneuploidy, genetic disorders, and chromosome structural rearrangements in embryos. These tests are mainly used by couples with advanced maternal age, recurrent pregnancy loss, repeated implantation failure, or a family history of genetic diseases.

Pre-implantation genetic testing PGT is categorized into three primary types:

  • PGT-A (Preimplantation Genetic Testing for Aneuploidy): This type evaluates embryos for chromosomal abnormalities, such as missing or extra chromosomes (aneuploidy). Aneuploidy can lead to conditions like Down syndrome, Edwards syndrome, and Patau syndrome.
  • PGT-M (Preimplantation Genetic Testing for Monogenic Disorders): PGT-M screens for specific genetic mutations that cause inherited single-gene disorders, such as cystic fibrosis, sickle cell anemia, and Huntington’s disease. It is particularly beneficial for individuals or couples with a known family history of such conditions.
  • PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements): This type identifies chromosomal structural rearrangements, such as translocations and inversions, which can impact embryo viability and increase the risk of miscarriage or genetic disorders.

The Pre-implantation genetic testing procedure involves several critical steps:

  • IVF Cycle: The process begins with an IVF cycle, where eggs are retrieved from the ovaries and fertilized with sperm in the laboratory to create embryos.
  • Embryo Biopsy: At the blastocyst stage (usually day 5 or 6), a few cells are carefully biopsied from each embryo. This biopsy does not harm the embryo’s developmental potential.
  • Genetic Analysis: The biopsied cells undergo genetic testing to identify any abnormalities. Techniques such as next-generation sequencing (NGS), polymerase chain reaction (PCR), and fluorescence in situ hybridization (FISH) are commonly used for this analysis.
  • Embryo Selection: Based on the genetic results, embryos that are free of identified genetic conditions or chromosomal abnormalities are selected for transfer.
  • Embryo Transfer: The selected embryos are transferred into the uterus for potential implantation and pregnancy.

Pre-implantation genetic testing offers numerous advantages for individuals and couples seeking to ensure the health of their future offspring:

  • Reducing the Risk of Genetic Disorders: PGT helps identify and avoid embryos carrying genetic mutations or chromosomal abnormalities, reducing the likelihood of genetic disorders.
  • Improving Pregnancy Outcomes: By selecting embryos with normal chromosomes, PGT increases the chances of successful implantation, reducing the risk of miscarriage.
  • Supporting Family Planning: For couples with a known genetic condition, PGT provides a valuable tool for making informed reproductive choices and planning a healthy family.
  • Optimizing IVF Success Rates: PGT improves IVF outcomes by identifying the healthiest embryos for transfer, enhancing overall pregnancy success rates.

While PGT holds promise, several considerations and ethical concerns should be addressed:

  • Genetic Privacy: The genetic information obtained from PGT raises questions about privacy and the potential misuse of genetic data.
  • Ethical Implications: The selection and discarding of embryos based on genetic screening can raise ethical dilemmas about the value and rights of embryos.
  • Access and Cost: PGT is a specialized procedure that may not be accessible or affordable for all individuals and couples, leading to disparities in reproductive healthcare.

Preimplantation genetic testing represents a significant advancement in reproductive medicine, offering hope and possibilities for individuals and couples facing genetic challenges. As technology continues to evolve, PGT’s role in ensuring healthy pregnancies and reducing genetic disorders will undoubtedly grow, shaping the future of reproductive health.

Source

0 Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

FertilityStudy Finds Simple Maternal Biomarker Test Reduces Neonatal Complications

Preterm birth is defined as any birth that occurs before 37 weeks of gestation and is the leading cause of illness and death among newborns. The 2023 March of Dimes Report Card reveals that more than one in ten infants were born prematurely in the United States in the past five consecutive years and for the third consecutive year, the March of Dimes Annual Report Card has given the United States a D+ for the country’s persistently high preterm birth rate.
Preterm Birth

FertilityThe Role of Lactobacillus in Preterm Birth

The vaginal microbiome plays an important role in influencing pregnancy outcome. Dominance of the vaginal niche by Lactobacillus species has been widely reported to be associated with a healthy, full-term pregnancy, specifically Lactobacillus crispatus. In contrast, diverse microbial communities depleted of Lactobacillus species and enriched with bacteria associated with Bacterial Vaginosis; a clinical syndrome characterized by vaginal discharge odor and polymicrobial overgrowth, increases the risk of adverse pregnancy outcomes including miscarriage and preterm birth. Preterm birth represents a significant global health burden.
Scent of A Woman

FertilityThe Scent of a Woman

In many species, female body odors reflect their reproductive status, and odors around the time of ovulation attract males, resulting in behavioral and/or physiological changes. In humans, several studies have suggested that female body odor signals periods of high fertility. For instance, vaginal secretions collected during the preovulatory and ovulatory phases are rated as more pleasant than those from the menstrual, early luteal, or late luteal phases. 

FertilityUterine Microbiome and Pregnancy

Summary Bacterial cells in the human body account for 1-3% of total body weight and are at least equal in number to human cells. Recent research has focused on understanding how the different bacterial communities in the body (eg, gut, respiratory, skin, and vaginal microbiomes) predispose to health and disease. The microbiome of the reproductive tract has historically been assumed to be identical to the vaginal bacterial flora, and the uterus classically was considered to be a sterile cavity but recently has been shown to have its own unique microbiome. A genital Lactobacillus-dominated flora plays a pivotal role in determining fertility. Lactobacilli dominate the microbial community and are commonly associated with a healthy genital status. Any pathological modification of this Lactobacillus-dominated flora is associated with poor reproductive outcomes. This finding adds a novel microbiological dimension to the reproductive process.
Natural Selection

FertilityNatural Selection: Two-Thirds of All Pregnancies Are lost But D’ont Despair

Don't despair, nature protects you and your child by selecting only the best embryos so that you have the best chance to give birth to a healthy child. This article will explain the natural selective process and its protective function. Perhaps more importantly we will suggest strategies that will help increase your odds of having a healthy child. One Strategy is egg freezing to ensure you have a young healthy egg available if you are not ready to have a child yet but want to keep your options open. The other is IVF where the embryologist selects only the highest quality embryos.